Back

Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled

European Heart Journal

23 July 2022
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Empagliflozin in a real-world chronic heart failure population
3 September 2019
thumbnail
Congress Presentation
Optimising heart failure therapy: potassium binders and the initiation and titration of mineralocorticoid receptor antagonists
19 May 2025
thumbnail
Congress Session
No time like the present: heart failure in the hospital setting
30 August 2024
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources